Skip to the content
Caishen.CoCaishen.Co
Primary Data for China's Secondary Investment and Stock Markets
  • Login
  • About
  • FAQ
  • Login
  • About
  • FAQ
  • Twitter
  • LInkedIn

Company: Hunan Nucien Pharmaceutical

Justify the volatility of the company's performance? Nanxin Pharmaceutical's reply to the annual report inquiry letter

  • Post date May 16, 2022 — 09:59 Post Lock Login to View

Read More

Nanxin Pharmaceutical lost 167 million in the following year, IPO raised 1.2 billion Western Securities sponsored wealth management channel Rongyi Information Network

  • Post date May 6, 2022 — 11:36 Post Lock Login to View

Read More

Nanxin Pharmaceutical disclosed that it achieved revenue of 197 million yuan in the first quarter of 2022 Teller Report

  • Post date May 5, 2022 — 11:09 Post Lock Login to View

Read More

Nanxin Pharmaceutical: The total amount of external guarantees of the company and its holding subsidiaries is about 365 million yuan

  • Post date April 30, 2022 — 11:21 Post Lock Login to View

Read More

Nanxin Pharmaceutical: Net profit in 2021 is about -167 million yuan

  • Post date April 30, 2022 — 11:21 Post Lock Login to View

Read More

Hunan Nanxin Pharmaceutical Co., Ltd. Announcement on Resolutions of the First Extraordinary General Meeting of Shareholders in 2022

  • Post date April 9, 2022 — 10:00 Post Lock Login to View

Read More

  • Twitter
  • LInkedIn
  • About Us
  • Contact Us
  • FAQ
  • Privacy Policy
  • Terms and Conditions
  • Corporate Subscription

Copyright © 2025 Caishen.Co. All rights reserved.

To the top ↑ Up ↑
China Money NetworkA service of China Money Network Ltd.